findmyKOL
Clinical trialNCT01355458CompletedPhase 3Interventional

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

SponsorGalderma R&DEnrollment260Rosacea
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Phase 3 efficacy and safety study of CD07805/47 topical gel in subjects with facial erythema associated with rosacea. The study hypothesis is that CD07805/47 gel, applied topically once daily is more efficacious than vehicle and provides an acceptable safety profile in the treatment of facial erythema associated with rosacea.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Lynderm Research Inc

    Markham, Ontario, Canada

  • Windsor Clinical Research Inc.

    Windsor, Ontario, Canada

  • Innovaderm Research, Inc

    Montreal, Quebec, Canada

United States
  • Dermatology Research Associates

    Los Angeles, California, United States

  • University of California, San Francisco

    San Francisco, California, United States

  • Michigan Center for Skin Care Research

    Clinton Township, Michigan, United States

  • Windsor Dermatology

    East Windsor, New Jersey, United States

  • Dermatology Consulting Services

    High Point, North Carolina, United States

  • Oregon Medical Research Center

    Portland, Oregon, United States

  • Philadelphia Institute of Dermatology

    Fort Washington, Pennsylvania, United States

  • the Skin Wellness Center

    Knoxville, Tennessee, United States

  • Arlington Center for Dermatology

    Arlington, Texas, United States

  • Dermresearch, Inc.

    Austin, Texas, United States

  • Dermatology Treatment & Research Center

    Dallas, Texas, United States

  • the Education & Research Foundation, Inc.

    Lynchburg, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CD07805/47 gelPlacebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2011
Primary completion
30 Sept 2011
Completion
31 Dec 2011
Last update posted
18 Feb 2021
Registered enrollment
260
Registry id
NCT01355458

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.